Cross-reactive displacing antibodies from collagen-binding...

Details Cross-reactive displacing antibodies from collagen-binding... Cross-reactive displacing antibodies from collagen-binding...

2007-07-10

2007-07-10

Siew, Jeffrey (Department: 1645)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S340000, C435S332000, C435S331000, C435S326000, C530S350000, C530S387100, C530S388100, C530S388400, C424S130100, C424S131100, C424S133100, C424S134100, C424S137100, C424S138100, C424S141100, C424S176100, C424S177100, C424S237100, C424S139100, C424S150100, C424S165100

Reexamination Certificate

active

09810428

ABSTRACT:
Antibodies to the CNA protein and to other regions from the collagen binding domain, including domain CNA19, are provided, and antibodies produced in this manner have been shown to be cross reactive to bothStaphylococcus aureusandStaphylococcus epidermidisbacteria and which can thus be used in the prevention and treatment of infections caused by both of these types of bacteria. In addition, medical instruments can be treated using the antibodies of the invention in order to reduce or eliminate the possibility of their becoming infected or further spreading the infection. In particular, the proteins are advantageous because they are cross-reactive and may thus be administered to patients so as to reduce or prevent severe infection by staphylococcal bacteria of more than one species. Antibodies generated in this manner have also been shown to exhibit displacement activity and can thus be utilized advantageously in methods wherein these antibodies will be administered to patients having pre-existing staphylococcal infections because of the ability to displace bacterial proteins from binding sites on the extracellular matrix. Finally, a method of identifying, isolating and utilizing displacing antibodies is also provided.

REFERENCES:
patent: 6288214 (2001-09-01), Hook et al.
patent: WO 97/43314 (1997-11-01), None
Patti et al ( Journal of Biological Chemistry. May 1992, vol. 267. No. 7, pp. 4764-4772).
Schiotz et al Acta.Pathol Microbiol Scand 1979, 87(6) 329-36.
Espersen et al (Acta.Pathol Microbiol Scand 1981, 89:253-260).
Longshaw et al Microbiology 2000, 146; 1419-1427.
Patti et al Biochemistry. Oct. 26, 1993; 32(42): 11428-35.
Symersky et al Nat. Struct Biol. Oct. 1997; 4(10): 833-8.
Foster et al., Surface protein adhesion ofStaphylococcus aureus, Trends in Microbiology 1998, vol. 6, No. 12, pp. 484-488.
Symersky et al., Structure of the Collagen-binding domain from aStaphylococcus aureusadhesion, Nature Structural Biology, Oct. 1997, vol. 4, No. 10, pp. 833-838.
Patti, Critical Residues in the Ligand-binding site of theStaphylococcus aureuscollagen-binding adhesion (MSCRAMM), Journal of Biological Chemistry, May 1995, vol. 270, No. 20, pp. 12005-12011.
Nehal Mohamed, Mark A. Teeters, Joseph M. Patti, Magnus Hook, Julia M. Ross; Inhibition ofStaphylococcus aureusAdherence to Collagen under Dynamic Conditions; Feb. 1999; pp. 589-594; vol. 67, No. 2; Infection and Immunity.
Lech M. Switalski, Joseph M. Patti, Wade Butcher, Anthony G. Gristina, Pietro Speziale, Magnus Hook; A collagen receptor onStaphylococcus aureusstrains isolated from patients with septic arthritis mediates adhesion to cartilage; 1993; pp. 99-107; vol. 7, No. 1; Molecular Microbiology.
Joseph M. Patti, Jeffrey O. Boles, Magnus Hook; Identification and Biochemical Characterization of the Ligand Binding Domain of the Collagen Adhesin fromStaphylococcus aureus; Oct. 26, 1993; pp. 11428-11435; vol. 32, No. 42; Biochemistry.
Visal et al., “Monoclonal Antibodies to CNA, a Collagen-binding Microbial Surface Component Recognizing Adhesive Matrix Molecules, . . . ”, The Journal of Biological Chemistry, vol. 275, No. 51, Issue of Dec. 22, 2000, pp. 39837-39845.
Patti et al., “Identification and Biochemical Characterization of the Ligand Binding Domain of the Collagen Adhesin fromStaphylococcus aureus”, Biochemistry 1993, 32, pp. 11428-11435.
Imundo et al., “Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface”,Proc. Natl. Acad. Sci. USA, vol. 92, pp. 3019-3023, Mar. 1995, Medical Sciences.

Affiliated with

Also associated with

Rating

Cross-reactive displacing antibodies from collagen-binding... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cross-reactive displacing antibodies from collagen-binding..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cross-reactive displacing antibodies from collagen-binding... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3755923